VWA
IBRX icon

Visionary Wealth Advisors’s ImmunityBio IBRX Stock Holding History

Visionary Wealth Advisors’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$431K Sell
49,260
-9,500
-16% -$71.9K 0.02% 461
2026
Q1 		$451K Buy
+58,760
New +$402K 0.02% 425

Other funds holding IBRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Visionary Wealth Advisors's IBRX Position: Q2 2026 in Review

Visionary Wealth Advisors reduced its ImmunityBio (IBRX) stake by 16% in Q2 2026, selling an estimated $71.9K and leaving 49,260 shares worth $431K. The position accounts for 0.02% of the portfolio, ranked #461.

Visionary Wealth Advisors first reported a position in IBRX in Q1 2026 and has held it in 2 quarters since. The position peaked at $451K in Q1 2026. 405 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

  • Visionary Wealth Advisors held 49,260 shares of ImmunityBio worth $431K as of Q2 2026.
  • Visionary Wealth Advisors sold 9,500 ImmunityBio shares in Q2 2026, an estimated $71.9K.
  • ImmunityBio made up 0.02% of Visionary Wealth Advisors's portfolio in Q2 2026, its #461 holding.
  • Visionary Wealth Advisors first reported a position in ImmunityBio in Q1 2026 and has held it in 2 quarters since.
  • Visionary Wealth Advisors's ImmunityBio position peaked at $451K in Q1 2026.
  • 405 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on Visionary Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.